CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 100 enrolled
Drug / intervention
Celecoxib +4 moredrug
Likely dose
Celecoxib 100mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04015908
NCT04015908Phase 4Completed
CompareCT.gov

A Multimodal Analgesia Protocol Adapted for Ambulatory Surgery

University of Utah·interventional·Posted Jul 11, 2019·Updated Jul 8, 2024

In Brief

A Phase 4 clinical trial evaluating Celecoxib, Acetaminophen, and 3 other interventions for Opioid Use. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The primary objective of this trial is to determine whether the combination of three non-opioid analgesics (multimodal analgesia) can significantly reduce or eliminate the need for opioids after ambulatory surgery. A secondary objective would be to present credible data for insurance providers about the opioid sparing effect of these medications. This data may encourage insurance providers to support payment for short term use of certain analgesics that currently require prior authorization.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid Use
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedJul 11, 2019
Enrollment StartAug 1, 2019
Primary CompletionJan 31, 2023
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 7.0 years ago

Interventions

Celecoxibdrug

Celecoxib 100mg

Acetaminophendrug

Acetaminophen 325mg

Pregabalindrug

Pregabalin 50 mg

Oxycodonedrug

oxycodone 5-10 mg

Percocetdrug

Percocet (oxycodone 5mg/acetaminophen 325 mg)